Kidney cysts are common, and the majority are incidental findings rather than part of a genetic condition. The questions that matter are whether the cysts are few and isolated or numerous and in both kidneys, whether anyone in the family has had kidney failure, and whether kidney function and blood pressure are drifting over time. Blood tests answer only part of that.
Most kidney cysts are simple cysts that become more common with age, not signs of an inherited disease. They are usually few in number, round, filled with clear fluid, and found by chance during a scan done for something else. They generally cause no symptoms and do not change how the kidneys filter.
Two other everyday situations produce cysts. Long-standing kidney disease of any cause can lead to acquired cysts that develop in kidneys already under strain. And occasional cysts show up as part of normal variation in kidney structure, which is why radiologists describe their number, size and location rather than simply noting that a cyst exists.
The inherited form is different in pattern. Autosomal dominant polycystic kidney disease (ADPKD) involves many cysts developing in both kidneys over decades, along with kidney enlargement and effects outside the kidneys 1. Research suggests that the cysts arise when tubule cells lose normal growth control and secrete fluid into expanding sacs, which gradually displaces working kidney tissue 2.
Separately, several ordinary factors move the blood markers used to follow kidney function without any cyst being involved. Hydration status, muscle mass, a heavy resistance training session, a very high protein intake, an acute illness and some medicines can all shift a creatinine reading. Ask your prescriber about anything you take before reading too much into one number.
Two routine blood markers carry most of the weight here, and both describe filtering capacity rather than cysts themselves. Guideline recommendations place repeated kidney function measurement at the centre of long-term follow-up in people with ADPKD, alongside blood pressure checks and imaging 3.
| Marker | Why clinicians check it | What a result can and cannot tell you |
|---|---|---|
| eGFR | Estimates how much blood the kidneys filter each minute, which is the single best routine summary of kidney function over time | Can show whether filtering capacity is stable, improving or declining across repeat tests. Cannot show cysts, kidney size or the cause of any change, and a single value is easily affected by hydration and recent training |
| Creatinine | A waste product from muscle that the kidneys clear, and the input the lab uses to calculate eGFR | Can flag a change in clearance and gives the raw number behind the estimate. Cannot separate a kidney cause from a muscle, diet or hydration cause on its own, and is interpreted differently depending on body size and sex |
Typical lab reference ranges for both markers look like this.
| Marker | Units | Typical lab reference range |
|---|---|---|
| Creatinine | mg/dL | About 0.7 to 1.3 in men, about 0.6 to 1.1 in women |
| eGFR | mL/min/1.73 m² | 90 or above regarded as normal filtering, under 60 persisting for three months or more regarded as reduced |
These are typical lab reference ranges, and they vary by laboratory, age and sex. Compare your own report against the range printed on it.
eGFR gives an estimate of filtering capacity, and tracking it over years is more informative than any single reading. The number is calculated from creatinine along with age and sex, and it is reported in mL/min/1.73 m², which scales the estimate to a standard body surface area.
In ADPKD, the timing is the awkward part. Studies indicate that filtering capacity often stays within the normal range for years while cysts enlarge and total kidney volume rises, because healthy nephrons compensate before the decline becomes visible in bloodwork 4. That is why a normal eGFR early on does not rule the condition out, and why imaging measures of kidney size are used alongside blood markers to judge how the condition is likely to progress 1.
A falling eGFR across several tests is an observation, not a diagnosis. It may reflect progressive kidney disease, or it may reflect dehydration, an acute illness or a recent change in something you take. The useful next step is a repeat test under ordinary conditions and a conversation with a clinician about the trend rather than the single figure.
Other things change eGFR without any kidney problem. Very high muscle mass, a large meat intake in the days before the draw, and intense exercise can all push creatinine up and the estimate down. Low muscle mass can do the opposite and make filtering look better than it is.
Creatinine measures a waste product produced at a fairly steady rate by muscle and cleared almost entirely by the kidneys. When clearance falls, creatinine in the blood rises, which is why it serves as the raw input for the eGFR calculation rather than as a standalone verdict.
In the inherited form of kidney cysts, serum creatinine tends to be a late signal. Reviews of ADPKD describe a long period in which structural change is well advanced before routine chemistry shifts, which is why follow-up pairs blood markers with imaging and blood pressure rather than relying on creatinine alone 5. A single creatinine inside the reference range is reassuring about current clearance and says nothing about cyst burden.
The interpretation runs in three steps. The value shows how much creatinine is circulating at that moment. A higher than usual result may reflect reduced clearance, more muscle, a high protein intake, hard training, dehydration or some medicines, and your prescriber is the person to ask about the last of those. What is worth doing next is repeating the test under normal conditions and reviewing the trend with a clinician, who can decide whether imaging or further testing makes sense.
Simple cysts are typically few, often one or two, usually in one kidney, and they do not enlarge the kidney or change its function. The inherited form shows many cysts distributed through both kidneys, with the kidneys themselves growing larger over time 6.
Age matters to that judgement. Because cysts become more common with age in the general population, the number of cysts needed before imaging points toward ADPKD rises as a person gets older, and radiologists apply age-specific criteria rather than a single cutoff 6. Ultrasound is the usual first look, with MRI or CT used when more detail or a kidney volume measurement is needed 3.
Family history shifts the interpretation more than almost anything else. A handful of cysts in a 60 year old with no relatives who had kidney failure reads very differently from the same picture in a 30 year old whose parent needed dialysis. Neither picture is a diagnosis you can make from a report at home, and both deserve a clinician's read.
If a scan mentions a complex cyst, with internal walls, solid parts or calcification, that is a separate question from PKD entirely and is followed up on its own terms. Bring the report to a clinician rather than sorting it out from the wording.
Many adults notice nothing for years, and the first finding is often raised blood pressure or an incidental scan. When symptoms do appear, they cluster around the kidneys. Flank or back pain, visible blood in the urine, kidney stones and urinary tract infections are all recognised features of ADPKD 7.
The condition also reaches beyond the kidneys. Liver cysts are the most common finding outside the kidney, and intracranial aneurysms occur more often in people with ADPKD than in the general population, which is why a family history of brain haemorrhage is specifically asked about 7. Abdominal fullness and discomfort can develop as the kidneys enlarge 1.
None of these symptoms belongs exclusively to kidney cysts. Back pain has dozens of ordinary explanations, and blood in the urine has several. What makes the combination worth raising is persistence, a family history of kidney disease, or blood pressure that has climbed without an obvious reason.
The dominant form passes down from a parent, and each child of an affected parent has a one in two chance of inheriting the variant. Most cases involve variants in one of two genes, usually described as PKD1 and PKD2, and the gene involved shapes how the condition tends to unfold 8.
That difference is real and worth understanding in words rather than numbers. Variants in PKD1, particularly those that truncate the protein, are associated with earlier loss of kidney function than variants in PKD2 8. Genetic testing is used selectively, for example when imaging is unclear, when family history is absent, or when the result would change how closely someone is followed 3.
For adult relatives, screening usually starts with a conversation and a blood pressure check, then imaging if that is appropriate. There are real considerations on both sides, including what an early result means for insurance, for planning and for peace of mind, and a clinician or genetic counsellor can work through them with you. Testing an adult relative is a decision, not a formality.
A negative scan in a young adult does not always settle the question, because cysts can appear later. That is one of the reasons genetic testing exists as an option when certainty matters.
Blood pressure is often the earliest abnormal finding, and it tends to rise before kidney function changes. Hypertension develops early and commonly in ADPKD, frequently before any fall in filtering capacity, which is why routine blood pressure measurement sits alongside kidney markers in follow-up 7.
Guideline recommendations place blood pressure control at the centre of long-term care in people with ADPKD, with the specific target and approach decided by the treating clinician for each person 3. Research suggests that cyst growth and kidney enlargement contribute to the activation of pressure-raising pathways inside the kidney itself, which helps explain why pressure climbs so early 2.
For anyone tracking this at home, consistency beats frequency. A measurement taken at a similar time of day, seated and rested, over a week, tells a clinician far more than a single reading taken after coffee and a rushed commute. Treatment decisions belong to a licensed provider.
A normal creatinine and eGFR do not rule out kidney cysts, because blood chemistry describes function and not structure. The long compensated phase of ADPKD means filtering can look entirely normal while cysts are enlarging, and imaging is what shows the structural change 4.
Several other things sit outside a standard blood panel. Kidney size and total kidney volume, which carry prognostic information in ADPKD, come from imaging rather than bloodwork 1. The genetic variant behind the condition is invisible to routine chemistry and requires specific testing. Protein or blood in the urine shows up on urine testing, not on a blood draw. Liver cysts and vascular findings are imaging questions.
There is also the ordinary noise problem. One blood draw captures one morning, and hydration, a hard training block and recent meals all leave fingerprints on creatinine. Two readings separated by weeks, taken under similar conditions, are worth more than one perfectly timed test.
This is why the useful framing is a trend plus a family history plus a blood pressure record, reviewed together by someone qualified to put them in context.
Some situations need prompt attention rather than a scheduled appointment. Severe or sudden flank, back or abdominal pain, visible blood in the urine, fever with flank pain or pain on urinating, a sharp drop in how much urine you pass, or blood pressure readings far above your usual numbers are all worth discussing with a clinician promptly.
Treat a sudden, severe headache unlike any you have had before as an emergency, especially alongside neck stiffness, vomiting, vision changes, weakness, numbness or difficulty speaking. Call emergency services rather than waiting, because this combination is the reason clinicians ask about a family history of brain haemorrhage in people with ADPKD.
Nothing on this page is a diagnosis, and no result should be ignored because an article described it as common. If a lab value sits outside the standard range, take it to a clinician rather than deciding what it means on your own.
If you are having thoughts of self-harm, call or text 988 (US) or your local emergency number now.
Both markers are standard blood tests, and both appear on the FitScript Essential panel, which includes creatinine along with the calculated eGFR. Membership covers 150+ biomarkers tested per year, so these values can be followed as a trend rather than read once in isolation.
Atlas, the AI health advisor, explains what each result means in plain language and shows how it has moved since your last draw. Atlas does not diagnose, and a licensed clinician reviews the picture and decides on any next step, including whether imaging, urine testing or specialist referral is appropriate.
For the cleanest reading, go into the draw in your usual state. That means normal hydration, no unusually heavy training in the day or two before, and no unusual protein load. Tell the clinician reviewing your results about everything you take, prescribed or otherwise, since some medicines influence creatinine and your prescriber can say which.
This article is educational and is not medical advice. Discuss your results and any treatment with a clinician or licensed provider who knows your history.
Most kidney cysts are simple, age-related and harmless to kidney function, while the inherited form involves many cysts in both kidneys and enlargement over decades. Creatinine and eGFR describe how well the kidneys filter, not whether cysts are present, and both can stay normal for years in ADPKD while structure changes. Blood pressure is often the earliest finding, and family history changes how any scan or lab result should be read. Imaging, urine testing and sometimes genetic testing answer the questions bloodwork cannot. A clinician interprets all of it together.
For more on the markers and the pressure connection, see the pages for eGFR and Creatinine, the FitScript Essential panel, and the explainer on does high blood pressure cause kidney disease.
PKD stands for polycystic kidney disease, an inherited condition in which many fluid-filled cysts develop in both kidneys and the kidneys gradually enlarge. It is different from the single simple cysts that are commonly found by chance on scans. Diagnosis rests on imaging, family history and sometimes genetic testing, and a clinician makes that call.
ADPKD means autosomal dominant polycystic kidney disease, the adult-onset inherited form. Autosomal dominant describes the inheritance pattern, where a single copy of the gene variant from one parent is enough, so each child of an affected parent has a one in two chance of inheriting it. Adult relatives can discuss screening options with a clinician.
Most kidney cysts are simple cysts that become more common with age, cause no symptoms and do not change kidney function. What matters is how many there are, whether both kidneys are involved, whether the cyst looks simple or complex on the scan, and whether anyone in your family has had kidney failure. Take the report to a clinician.
No. Creatinine and eGFR describe how well the kidneys are filtering, not whether cysts are present. Imaging, usually an ultrasound first, is what shows cysts and kidney size. Blood markers are used alongside imaging and blood pressure to follow kidney function over time.
It means your kidneys are currently filtering within the expected range, which is reassuring about function today. It does not tell you how many cysts there are or how much the kidneys have enlarged. Clinicians usually follow eGFR as a trend across repeat tests rather than reading one value in isolation.
A single rise has many ordinary explanations, including dehydration, a hard training session, a high protein intake, more muscle mass, a recent illness or some medicines. Ask your prescriber about anything you take. The sensible next step is a repeat test under your usual conditions, reviewed with a clinician alongside your previous results.
Adult relatives of someone with the inherited form often discuss screening with a clinician, which usually starts with a blood pressure check and a conversation about family history, then imaging if appropriate. Genetic testing is an option in some situations. It is a personal decision with practical implications, so talk it through with a clinician or genetic counsellor.
There is no single answer, because the interval depends on your kidney function, blood pressure, family history and what a previous scan showed. A clinician who knows your history sets the schedule. If you are testing through a membership panel, bring each new result into that same conversation rather than interpreting it alone.